Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Attenuated Vaccine Repurposed as an Innate Immune-based Preventive Against COVID-19-associated Sepsis/Inflammation
NCT04475081Phase 3Completed
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Sep 2020
- Primary completion
- May 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of measles, mumps, and rubella vaccine in coronavirus disease 2019 (COVID-19), sepsis, sponsored by Louisiana State University Health Sciences Center. Started Sep 2020; status: completed.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)sepsis
Beyond the preview
Go deeper on NCT04475081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475081.